EyePoint Pharmaceuticals, Inc. (EYPT)
$3.40-1.73%Close
SELLCRISIS · day 39
Key stats
Short interest · FINRA settlement 2026-09-30
- Market cap
- $285M
- Beta
- 1.68
- P/E (TTM)
- -0.85
- Short % float
- 29.50%
- Days to cover
- 5.4
- SI change
- +4.9%
- 1W
- +4.62%
- 1M
- -20.00%
- vs SPY 1W
- +3.46%
- vs SPY 1M
- -22.99%
Industry peers
FMP comparable companies · ranked by market cap
- KODBUYKodiak Sciences Inc.$5.8BBULLQ 42$92.34+5.95%
- TNGXSELLTango Therapeutics, Inc.$3.6BRECOVERYQ 24$21.90+5.49%
- NRIXSELLNurix Therapeutics, Inc.$2.3BBEARQ 11$22.60+0.63%
- SEPNSELLSepterna Inc$1.6BRECOVERYQ 28$35.67+3.98%
- BCAXSELLBicara Therapeutics Inc. Common Stock$1.1BCRISISQ -9$16.56+1.39%
- SVRASELLSavara Inc.$953MRECOVERYQ 11$4.65+1.86%
- KURASELLKura Oncology, Inc.$935MBEARQ 12$10.53+0.76%
- PRMEBUYPrime Medicine, Inc.$632MRECOVERYQ -6$3.50+11.45%
- PROKSELLProKidney Corp.$538MRECOVERYQ 1$1.60+4.82%
Prediction markets
Kalshi · Polymarket · … linked
Loading markets…